BDP® 558/568 carboxylic acid
Cat. # | Quantity | Price | Lead time | Buy this product |
---|---|---|---|---|
17490 | 1 mg | $125 | in stock | |
27490 | 5 mg | $260 | in stock | |
47490 | 25 mg | $510 | in stock | |
57490 | 50 mg | $895 | in stock | |
67490 | 100 mg | $1490 | in stock |
BDP 558/568 is a universal borondipyrromethene dye with emission in the yellow region of the spectrum. This derivative is a free carboxylic acid.
Absorption and emission spectra of BDP 558/568
Customers also purchased with this product
BDP® 630/650-X-NHS ester
BDP 630/650 is a borondipyrromethene fluorophore tuned to Cyanine5 excitation and emission channels. The dye is bright and highly photostable. It is useful for fluorescence polarization assays. This is an amine-reactive NHS ester derivative.Cyanine3 carboxylic acid
The free carboxylic acid of Cyanine3 dye. Non-sulfonated dye, with good solubility in organic solvents, and limited aqueous solubility.Cyanine7 NHS ester
Amine reactive NHS ester of near infrared fluorescent dye, an improved analog of Cy7®.General properties
Appearance: | dark colored solid |
Molecular weight: | 346.16 |
CAS number: | 150173-72-1 |
Molecular formula: | C16H13N2BF2O2S |
Solubility: | good in DCM, DMF, DMSO |
Quality control: | NMR 1H, HPLC-MS (95%) |
Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
MSDS: | Download |
Product specifications |
Spectral properties
Excitation/absorption maximum, nm: | 561 |
ε, L⋅mol−1⋅cm−1: | 84400 |
Emission maximum, nm: | 569 |
Fluorescence quantum yield: | 0.68 |
CF260: | 0.00 |
CF280: | 0.07 |
Product citations
- Kochappan, R.; Cao, E.; Han, S.; Hu, L.; Quach, T.; Senyschyn, D.; Ferreira, V.I.; Lee, G.; Leong, N.; Sharma, G.; Lim, S.F.; Nowell, C.J.; Chen, Z.; von Andrian, U.H.; Bonner, D.; Mintern, J.D.; Simpson, J.S.; Trevaskis, N.L.; Porter, C.J.H. Targeted delivery of mycophenolic acid to the mesenteric lymph node using a triglyceride mimetic prodrug approach enhances gut-specific immunomodulation in mice. Journal of Controlled Release, 2021, 332, 636–651. doi: 10.1016/j.jconrel.2021.02.008
BDP® is a trademark of Lumiprobe
This Product is offered and sold for research purposes only. It has not been tested for safety and efficacy in food, drug, medical device, cosmetic, commercial or any other use. Supply does not express or imply authorization to use for any other purpose, including, without limitation, in vitro diagnostic purposes, in the manufacture of food or pharmaceutical products, in medical devices or in cosmetic products.
Your item has been added.
View your
cart
or
proceed to checkout
The count of items is incorrect.